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Background: Implementation of four-dimensional flow magnetic resonance (4D Flow MR) in clinical routine requires
awareness of confounders.
Purpose: To investigate inter-vendor comparability of 4D Flow MR derived aortic hemodynamic parameters, assess scan-
rescan repeatability, and intra- and interobserver reproducibility.
Study Type: Prospective multicenter study.
Population: Fifteen healthy volunteers (age 24.5  5.3 years, 8 females).
Field Strength/Sequence: 3 T, vendor-provided and clinically used 4D Flow MR sequences of each site.
Assessment: Forward flow volume, peak velocity, average, and maximum wall shear stress (WSS) were assessed via nine
planes (P1–P9) throughout the thoracic aorta by a single observer (AD, 2 years of experience). Inter-vendor comparability
as well as scan-rescan, intra- and interobserver reproducibility were examined.
Statistical Tests: Equivalence was tested setting the 95% confidence interval of intraobserver and scan-rescan difference
as the limit of clinical acceptable disagreement. Intraclass correlation coefficient (ICC) and Bland–Altman plots were used
for scan-rescan reproducibility and intra- and interobserver agreement. A P-value <0.05 was considered statistically signifi-
cant. ICCs ≥ 0.75 indicated strong correlation (>0.9: excellent, 0.75–0.9: good).
Results: Ten volunteers finished the complete study successfully. 4D flow derived hemodynamic parameters between scan-
ners of three different vendors are not equivalent exceeding the equivalence range. P3–P9 differed significantly between
all three scanners for forward flow (59.1  13.1 mL vs. 68.1  12.0 mL vs. 55.4  13.1 mL), maximum WSS
(1842.0  190.5 mPa vs. 1969.5  398.7 mPa vs. 1500.6  247.2 mPa), average WSS (1400.0  149.3 mPa vs.
1322.6  211.8 mPa vs. 1142.0  198.5 mPa), and peak velocity between scanners I vs. III (114.7  12.6 cm/s
vs. 101.3  15.6 cm/s). Overall, the plane location at the sinotubular junction (P1) presented most inter-vendor stability
(forward: 78.5  15.1 mL vs. 80.3  15.4 mL vs. 79.5  19.9 mL [P = 0.368]; peak: 126.4  16.7 cm/s vs. 119.7  13.6 cm/s
vs. 111.2  22.6 cm/s [P = 0.097]). Scan-rescan reproducibility and intra- and interobserver variability were good to excel-
lent (ICC ≥ 0.8) with best agreement for forward flow (ICC ≥ 0.98).
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Data Conclusion: The clinical protocol used at three different sites led to differences in hemodynamic parameters
assessed by 4D flow.
Level of Evidence: 2
Technical Efficacy Stage: 2
J. MAGN. RESON. IMAGING 2021.
Three-dimensional (3D) cine (time-resolved) phase-contrast magnetic resonance with three-directional
velocity-encoding (4D Flow MR) allows quantification and
visualization of hemodynamics in the heart and great ves-
sels.1–3 It has been shown to be useful in different diseases for
the evaluation of blood flow patterns and derived hemody-
namic parameters, such as wall shear stress (WSS).4 WSS is
elevated in patients with severe aortic stenosis and/or bicuspid
aortic valve, as well as in aortic valve replacements.5–8 In sys-
temic diseases with affection of the aorta, WSS is also altered.
In patients with Marfan syndrome, these alterations included
a local decrease in average WSS in the outer proximal ascend-
ing segment and an increase in the inner distal ascending
aorta.9 This additional information may help with clinical
decision-making and therapy guiding in diseases.
The potential of integrating 4D Flow MR into daily
clinical routine has been increased due to several image
acceleration techniques, such as parallel imaging, yielding
scan times for the assessment of aortic flow of under
2 minutes.10 However, awareness of confounders is now of
vital importance for successful implementation in the clini-
cal setting.
4D Flow MR acquisitions have been applied using vari-
ous protocols and different scanner types.1–11 Although the
acquisition of the whole heart is routinely recommended in
congenital heart diseases, while the acquisition of the aorta is
mainly used for aortic and aortic valve diseases, no consensus
has been established on which technique to use in adults.12,13
Additionally, 4D Flow MR sequences differ between sites
with scanners from different vendors regarding their acquisi-
tion parameters, as each vendor has made different adjust-
ments in the sequence and in the recommended protocol for
optimal acquisition.
For other quantitative parameters like T1 mapping or
myocardial strain, variability of results in dependence on dif-
ferent manufacturers is known, thus indicating that variability
may also exist in 4D Flow MR.14,15 Without this information
on inter-vendor agreement, comparison of 4D Flow MR
examinations provided by scanners from different vendors
may be difficult in the clinical environment.
Therefore, the aims of this study were to:
1. Examine the inter-vendor comparability and reproducibil-
ity of 4D Flow MR derived aortic hemodynamic parame-
ters at scanners of three different vendors in order to
evaluate if 4D Flow MR examinations acquired at differ-
ent sites under diverging conditions are equivalent.
2. Test for scan-rescan reproducibility at one scanner for
hemodynamic variability.
3. Determine the intra- and interobserver agreement for eval-
uation of hemodynamic parameters.
Materials and Methods
Study Population
Ethical approval was obtained by the local ethics committee
(approval number EA2/208/17). The study complied with the Dec-
laration of Helsinki. It was registered at the German Clinical Trials
Register (registration number: 00013253) and the World Health
Organization (universal trial number: U1111-1207-5874). Informed
written consent was obtained from each participant prior to study
enrollment. Healthy volunteers without a history of cardiovascular
diseases were recruited and underwent three cardiovascular MR scans
using different scanner types. Cardiovascular MR examinations veri-
fied normal left ventricular function and a tricuspid aortic valve
without pathology.
Image Acquisition
Volunteers were scanned at three different sites (scanners I–III).
Each site was using a 3-T wide-bore scanner of different vendors
(scanners sorted alphabetically not corresponding to sites): Ingenia
(Philips, Best, The Netherlands), SIGNA Architect (GE Healthcare,
Milwaukee, WI, USA), and MAGNETOM Verio (Siemens
Healthineers, Erlangen, Germany). The same scan protocol was per-
formed in all volunteers. Heart rate was recorded during each 4D
Flow MR acquisition, while blood pressure was measured before
each 4D Flow MR scan. At one site (scanner III) an additional 4D
Flow MR acquisition for scan-rescan reproducibility was performed
after a short break of 20–30 minutes, where the volunteers left the
scanner requiring repositioning of the coil and replanning of image
acquisition afterwards.
To validate the current level of agreement in 4D flow imaging
of the aorta in a real-life setting, the clinical 4D Flow MR sequence
of each site was used to image the volunteers. The study refrained of
adapting sequence parameters to the published consensus paper as
common ground to avoid potential bias favoring one vendor and to
reflect the current clinical application of 4D Flow MR sequences.2
Acquisition parameters between the scanners varied due to different
vendor-provided protocols and each site’s individual adjustments for
optimal clinical use (Table 1).
The acquisition volume was defined according to the vendor’s
recommendation: on scanner III the scan covered the aorta, on scan-
ners I and II the whole heart. For cardiac gating, an electrocardio-
gram (ECG) was used in all cases. On scanner III, prospective
cardiac gating was applied along with a cross-paired respiratory navi-
gator placed on the lung–liver interface allowing for free breathing.
Retrospective triggered ECG gating without a respiratory navigator
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TABLE 1. Sequence Parameters of the Different Scanners






























2.8  2.8  2.8 2.4  2.4  2.8 2.7  2.3  2.6
Reconstructed
voxel size (mm3)
1.3–1.9  1.3–1.9  2.8 1.4–1.5  1.4–1.5  1.4 2.3  2.3  2.6
Field of view
(mm3)









Multi-element receive coil array with
flexible number of up to
32 elements
Multi-element receive coil array with








Encoding scheme 4-point symmetric with Hadamard
encoding









10.8 (1.2) 10.5 (1.5) 8.0 (2.2)
Number of cardiac phases and acquisition duration are presented as mean  SD.
ECG = electrocardiogram; R = acceleration factor; kt = k-adaptive-t; MPS = measurement/phase/slice.
aUsed vendor-specific techniques in alphabetical order: Autocalibrating Reconstruction for Cartesian sampling (ARC), GeneRalized
Autocalibrating Partially Parallel Acquisition (GRAPPA), and Sensitivity Encoding (SENSE).
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was used at scanners I and II. Based on site routine, the velocity
encoding (VENC) value was set to 150 cm/s at scanners II and III,
and to 250 cm/s at scanner I. Acquisition time differed between the
volunteers, depending on heart rate and breathing quality.
Image Analysis
All 4D Flow MR images were analyzed by a single observer (AD,
2 years of 4D Flow MR experience) using CAAS MR Solutions 5.0
(Pie Medical Imaging BV, Maastricht, The Netherlands).16 Maxwell
fields were corrected in all MR systems automatically during image
reconstruction.17 Background phase offset correction using a linear
fit and phase unwrapping were performed in all datasets.2,18 In the
applied software version, phase unwrapping was not possible for
the data acquired at scanner II. Therefore, all images (including
those from scanners I and III) were manually screened by the
observer (AD) for potential phase aliasing, and in cases where phase
aliasing occurred inside a plane region, the plane was excluded.
For segmentation of the aorta, the start point was placed in
the upper region of the left ventricular outflow tract and the end
point in the descending aorta below the cardiac apex (Fig. 1b). As
previously described, a phase-specific segmented 3D aortic surface
model was automatically detected for five cardiac phases and the
peak systolic phase was selected for implementation of
the succeeding analysis steps.19,20 If necessary, this 3D volume
model was manually corrected by the observer by editing the vessel
boundary contours for each aortic 2D plane in the peak systolic
phase (Fig. 1c) updating the centerline subsequently. In case of miss-
ing or truncated aortic segments, the scan was excluded from further
evaluation.
Nine cross-sectional planes were positioned along the center-
line (Figs. 1 and 2). Contours of the vessels were projected automati-
cally on each plane based on the 3D segmentation of the selected
peak systolic phase and, if needed, manually adapted for all phases
along the cardiac cycle. Peak velocity and forward flow volume were
evaluated. For WSS analysis the identical plane locations were
FIGURE 1: Process of 4D Flow MR analysis with CAAS. (a) Preprocessing with background phase offset and aliasing correction. (b)
Segmentation of the aorta: determining the start and end point of the centerline using a 3D display of the heart and great vessels.
(c) Segmentation of the aorta: editing the Mesh model based on the static tissue for each 2D plane along the aorta in the peak
systolic phase. The Mesh model represents a 3D volume model of the aorta for one cardiac phase. It is automatically generated for
five cardiac phases (peak systolic phase  2 cardiac phases). We selected the peak systolic phase for subsequent manual
segmentation and analysis. (d) Localization of the nine planes in the thoracic aorta for analysis of flow parameters with exemplary
drawn vessel contours for plane 9.
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automatically transferred. WSS was automatically calculated based
on the segmented 3D volume model for the peak systolic phase and
extrapolated to the point of zero velocity for defining the location of
the aortic wall.21 No manual adaption was necessary. For each plane,
the WSS vector along the surface of the 3D model was calculated
for 90 wall points. Maximum WSS was determined as the highest of
all WSS values and average WSS as the average of all WSS values in
the peak systolic phase.
For intraobserver analysis, the scans of all 10 volunteers at all
three scanners (30 scans in total) were evaluated twice. All scans were
analyzed by a blinded second observer (SW, 5 years of 4D Flow MR
experience, >10 years of MR experience) for interobserver analysis as
well. Both analyses only included plane positions in the ascending
aorta (P1–P3) as most clinically relevant pathologies occur in this
region.
Statistical Analysis
Statistical analyses were performed with SPSS (V25.0, IBM Corp.,
Armonk, NY, USA) and SAS (V9.4, SAS Institute Inc., Cary, NC,
USA). Bland–Altman analyses were generated for agreement of the
values acquired at the different scanners. As previously published, for
equivalence testing the 95% confidence interval (CI) of the
intraobserver difference for each parameter was set as the margin of
acceptable disagreement regarding the comparison between ven-
dors.22 Results from two vendors were considered equivalent if the
limits of their difference would lie within the 95% CI of
FIGURE 2: Visualization of the 4D Flow MR data obtained by the different scanners for evaluation of flow parameters (a) and wall
shear stress (WSS) (b) from one volunteer. (a) Nine cross-sectional planes were positioned along the centerline and perpendicularly
to the longitudinal axis of the aortic wall as follows: at the level of the sinotubular junction (P1), in the mid-ascending aorta (P2),
proximal to the brachiocephalic trunk (P3), between the brachiocephalic trunk and the left common carotid artery (P4), between the
left common carotid artery and the left subclavian artery (P5), at the aortic isthmus (P6), in the descending aorta above the
pulmonary artery (P7), in the descending aorta below the pulmonary artery (P8), in the descending aorta below the level of
the aortic valve (P9). (b) Distribution of maximum WSS is visualized in a 3D segmented model of the aorta for the peak systolic
phase. As shown in the color bar red-colored areas represent highest values for maximum WSS. The color bars were adjusted as far
as possible between the three acquisitions for better visual comparison.
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intraobserver difference. Additionally, equivalence was tested using
the 95% CI of scan-rescan difference as the accepted range. Signifi-
cance testing was performed for each plane separately using the
Wilcoxon and Friedman tests. Numeric data of the combined planes
(eg, P1–P9) were stated as the mean  SD of their average value.
Linear mixed models with repeated measures taking into account the
correlation of multiple observations per patient were additionally
applied to determine statistically significant differences jointly for the
planes P1–P9 as well as in the ascending aorta (P1–P3), aortic arch
(P4–P6), and descending aorta (P7–P9). A hierarchical test strategy
was used. Only if significance was shown in the global test (scanner
I vs. II vs. III) significance was assessed in the pairwise comparison
between two scanners also at a two-sided level of 5%.
Depending on the distribution (normal vs. non-normal), sig-
nificance of scan-rescan variability was tested with the paired t-test
or Wilcoxon test. For agreement of scan-rescan reproducibility,
Bland–Altman analyses and the intraclass correlation coefficient
(ICC) were calculated. ICC was interpreted as follows: >0.9: excel-
lent, 0.75–0.9: good, 0.5–0.75: moderate, <0.5: poor.23 Intra- and
interobserver reliability was determined using the ICC and Bland–
Altman plots.
Results
Fifteen healthy volunteers (mean age 24.5  5.3 years,
8 females) without a history of cardiovascular diseases were
enrolled in the study. Baseline characteristics are provided in
Table 2. Out of these, 10 volunteers completed the study
and could be included in further analysis. Following circum-
stances resulted in exclusion of the five volunteers. Due to
unexpected technical problems, one volunteer could not be
scanned at scanner II. Three datasets from scanner I were lost
due to incomplete reconstruction after data acquisition.
Another 4D Flow MR acquisition obtained at scanner I was
excluded as inaccurate image planning led to missing aortic
segments. In one volunteer, one plane (P2) had to be
excluded as the aortic segment was truncated during image
planning, while aliasing led to an exclusion of two additional
planes (P1, P5) in two other volunteers. In total, we analyzed
90 segments and 267 planes in 10 volunteers. The time
period between the first and second scan sessions (at scanners
I and II) was 103  4 days, while the second and third scans
were performed within 18  10 days.
Comparison of Different Vendors
Average heart rate did not differ significantly between the scans
(69.6  9.4 bpm vs. 77.4  6.8 bpm vs. 78.9  13.5 bpm;
P = 0.067). Systolic and diastolic blood pressure levels signi-
ficantly varied (sys: 111.0  10.0 mmHg vs. 121.4 
11.8 mmHg vs. 118.8  10.1 mmHg; dia: 59.8  5.4 mmHg
TABLE 2. Baseline Characteristics of the Healthy Volunteers
Variables Inter-Vendor (N = 10) Scan-Rescan (N = 15)
Gender (female) 6 8
Age (years) 24.1 (5.4) 24.5 (5.3)
Height (cm) 174.1 (7.2) 173.9 (8.8)
Weight (kg) 66.2 (10.5) 65.6 (10.6)
BMI (kg/m2) 21.7 (2.2) 21.6 (2.2)
BSA (m2) 1.8 (0.2) 1.8 (0.2)
LVEDV (mL) 145.4 (31.5) 146.6 (32.6)
LVEF (%) 63.8 (4.5) 64.7 (4.8)
Heart rate at scanner I (bpm)
Heart rate at scanner II (bpm)




P = 0.067 76.1 (11.5)
76.1 (11.1)
P = 0.986
Blood pressure at scanner I
(mmHg)
Blood pressure at scanner II
(mmHg)
















Values are presented as mean  SD.
BMI = body mass index; BSA = body surface area; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection
fraction.
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vs. 69.0  8.0 mmHg vs. 60.4  6.1 mmHg). Figure 2
exemplary illustrates a visual impression of the analyzed 4D
Flow MR data from one volunteer at the three different
scanners.
Forward flow volume showed significant differences
between all scanners regarding P3–P9 (59.1  13.1 mL
vs. 68.1  12.0 mL vs. 55.4  13.1 mL), and for the des-
cending aortic segment (52.2  12.4 mL vs. 60.7  13.3 mL
vs. 50.1  12.3 mL) (Tables S1 and S2 in the Supplemental
Material). Only P1, located at the sinotubular junction, indi-
cated no difference for pairwise comparison (I vs. II
P = 0.110; I vs. III P = 0.646; II vs. III P = 0.314), as well
as for comparison of all three vendors (78.5  15.1 mL
vs. 80.3  15.4 mL vs. 79.5  19.9 mL; P = 0.368). For-
ward flow volume between the values obtained from scanners
I and III agreed best in Bland–Altman analyses (Table 3,
Fig. S1 in the Supplemental Material), while the highest
values were detected by scanner II. Peak velocity differed sig-
nificantly between the three scanners within the descending
aortic segment (125.6  17.5 cm/s vs. 113.7  13.2 cm/s
vs. 111.1  19.1 cm/s) and in a pairwise or three-way com-
parison within all planes except P1 (126.4  16.7 cm/s
vs. 119.7  13.6 cm/s vs. 111.2  22.6 cm/s; P = 0.097)
(Tables S1 and S2 in the Supplemental Material). Highest
values for peak velocity resulted from scanner I, lowest from
scanner III. In Bland–Altman analyses the results of scanners
II and III were most comparable (Table 3, Fig. S1 in the
Supplemental Material). Equivalence could not be concluded
for both flow parameters as the range of 95% CI of differ-
ences between the scanners exceeded the margin of
intraobserver variability. When setting the 95% CI of scan-
rescan variability as accepted range, only the difference
between scanners II and III for peak velocity laid within the
limits and were therefore found to be equivalent (Fig. 3,
Table 3).
Maximum WSS varied significantly between all scanners
for P1–P9, aortic arch, and the descending aorta as well as all
planes separately except P1 (P = 0.062) and P2 (P = 0.121)
(Tables S1 and S2 in the Supplemental Material). Average
WSS results were similar, revealing a non-significant differ-
ence only for P2 (P = 0.264) and the ascending aortic seg-
ment (P = 0.357). Lowest values for maximum and average
WSS resulted from data of scanner III (WSS max:
I = 1790.5  172.4 mPa vs. II = 1903.2  430.5 mPa vs.
III = 1458.7  238.8 mPa; WSS avg:
I = 1344.6  136.9 mPa vs. II = 1251.9  214.2 mPa vs.
III = 1102.8  187.6 mPa). Between scanners I and II, no
significant difference for maximum WSS in all planes
(P = 0.406) and segments (ascending: P = 0.622, arch:
P = 0.961, descending: P = 0.297) and only significant dif-
ferences in P5, P9, and the aortic arch for average WSS could
be observed (ascending: P = 0.204, descending: P = 0.555)
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parameters exceeded the margin of intraobserver and scan-
rescan variability as accepted difference (Fig. 3, Table 3).
Scan-Rescan Reliability
All 15 volunteers were scanned twice at scanner III and no acqui-
sition or plane had to be excluded. Average heart rate
(76.1  11.5 bpm vs. 76.1  11.1 bpm; P = 0.986) and blood
pressure (sys: 119.4  12.0 mmHg vs. 123.7  17.1 mmHg
[P = 0.116]; dia: 61.5  9.6 mmHg vs. 60.6  10.5 mmHg
[P = 0.599]) did not vary significantly between scan and rescan.
No significant difference was found for all parameters in all
planes and segments (P1–P9: peak = 102.4  14.6 cm/s
vs. 101.7  18.1 cm/s [P = 0.859]; forward flow =
60.0  13.2 mL vs. 59.5  13.7 mL [P = 0.621]; WSS
max = 1470.4  207.8 mPa vs. 1446.4  284.5 mPa [P =
0.955]; WSS avg = 1118.3  163.3 mPa vs. 1105.2 
211.7 mPa [P = 0.795] (Table S3 in the Supplemental Mate-
rial). Agreement for forward flow volume was excellent
(ICC = 0.98) and good for peak velocity (ICC = 0.83), average
WSS (ICC = 0.84), and maximum WSS (ICC = 0.80). Bland–
Altman analyses showed good agreement with narrow CI
(Table 3, Fig. 4). Equivalence set by the intraobserver variability
could not be concluded as all parameters exceeded the margin
(Fig. 3, Table 3).
Inter- and Intraobserver Reliability
Bland–Altman plots and ICC indicated excellent
intraobserver reproducibility (forward flow: ICC = 1.0; peak
velocity: ICC = 0.99; maximum WSS: ICC = 0.99; average
WSS: ICC = 1.0; Table 3, Fig. 4).
Excellent interobserver agreement was achieved for for-
ward flow (ICC = 0.99), peak velocity (ICC = 0.96), and
maximum WSS (ICC = 0.92), while average WSS displayed
good agreement (ICC = 0.86) (Fig. 4).
Discussion
This study revealed significant differences for 4D flow derived
hemodynamic parameters when using vendor-provided and
clinical used protocols at three different sites. All parameters
exceeded the equivalence range set by the intraobserver analy-
sis. For representation of the real clinical setting and the cur-
rent level of standardization each site used their individual
and vendor-provided standard 4D Flow MR sequence for
acquisition. The study results do not provide information
FIGURE 3: Equivalence testing for inter-vendor comparison in relation to intraobserver and scan-rescan variability for peak velocity
(a), forward flow volume (b), maximum wall shear stress (WSS) (c), and average WSS (d). Equivalence of two vendors is shown if the
95% confidence interval (CI) for the scanner comparison (indicated as gray vertical bars) lays within the equivalence limits of the
intraobserver variability (blue dashed lines) or scan-rescan variability (green dashed lines). The dashed lines display the range of
intraobserver/scan-rescan variability as 95% CI of the differences of the measured values.
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about which of the 4D flow sequences is the most accurate or
precise. However, they show that 4D flow derived hemody-
namic parameters cannot easily be compared for a follow-up
when a subject is examined at different scanners under diverg-
ing conditions, exemplary different vendors, and/or sites.
Also, the differences in protocols identify the lack of commer-
cial 4D Flow MR sequences across platforms and centers in
the clinical routine, yet reflecting the current status quo.
Additionally, many data sets or planes needed to be discarded,
highlighting the complexity of this method despite continu-
ous technical development of 4D Flow MR sequences and
postprocessing tools.
Bock et al validated 4D Flow MR sequences in a phan-
tom and in vivo comparing flow volumes between a 1.5-T
Siemens and Philips scanner, which showed a larger variation
of kinetic energy between the two scanner types than between
repeated measurements at one scanner.24 This is in line with
the findings of this study.
Watanabe et al investigated the impact of changing the
vendor of the scanner on flow velocity using a straight-tube
phantom. Their results showed satisfying accuracy of flow
velocity profiles in all three 3 T scanners (GE, Philips, Sie-
mens).25 Additionally, they measured time-averaged flow
velocity perpendicular to the tube central, which
FIGURE 4: Bland–Altman plots for scan-rescan reproducibility and intra- and interobserver variability of peak velocity (a), forward
flow volume (b), maximum wall shear stress (WSS) (c), and average WSS (d). Solid black lines indicate mean difference, dashed lines
indicate limits of agreement (95% confidence interval of the differences of the measured values).
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corresponded well with the reference values obtained by a
flowmeter for each vendor, but reference values slightly dif-
fered between the scanners. Absolute values for peak velocity
were also similar between the scanners in the present study.
Further, a statistical analysis including equivalence testing as a
method for accepted difference range from clinical perspective
was performed. Peak velocity was the most stable parameter
as equivalence was achieved between two scanners within the
limits of scan-rescan variability.
Wen et al evaluated the multicenter reproducibility of
neurovascular 4D flow magnetic resonance imaging (MRI)
scans on 10 healthy volunteers at three different sites using a
3-T GE scanner with identical coils and acquisition
parameters. They observed great multisite reproducibility for
measurement of blood flow and good reproducibility for peak
velocity in intracranial vessels.26 Their findings suggest the
significant disagreement in 4D flow parameters detected in
the present study to be rather induced by the vendor-
associated difference of acquisition parameters than practical
experience in the different sites.
Systolic and diastolic blood pressure levels varied signifi-
cantly between the scans indicating hemodynamic changes in
each volunteer. These physiological changes may have been
induced by differences in fluid or food intake before 4D Flow
MR acquisition, as the volunteers did not fast.27 However,
absolute values of blood pressure levels were similar and from
a clinical perspective this discrepancy represents no clinical
relevance as heart rate did not differ significantly. Addition-
ally, all three scanners were wide-bore (70 cm) scanners lead-
ing to a similar level of rather common claustrophobia
induced stress. This minimalizes the potential influence on
hemodynamic parameters caused by different levels of claus-
trophobic stress. Also, in larger bores effects due to a more
heterogeneous field are commonly found.
Since the plane at the level of the sinotubular junction
(P1) showed the lowest number of significant differences in
hemodynamic parameters, we considered this region as the
most stable plane location. Additionally, when comparing
the cardiac outputs resulting from the cine images and the
4D flow analysis (forward volume at P1  heart rate during
4D flow) exemplarily for all 15 volunteers at scanner III, no
significant difference could be found. This can serve as an
external validation of the 4D flow derived flow volumes in
this study.
The stability of P1 is especially interesting for clinical
purposes as the position is identical to the localization applied
in clinically used 2D flow measurements holding clinical
importance for diagnosis of aortic flow measurements.28 This
stability could be explained by its central location indepen-
dent of the defined acquisition volume (whole heart
vs. aorta). Plane positions that are more distant from the
isocenter of the magnet rather lead to inaccurate flow results
mainly caused by eddy currents yielding phase offsets.29
Therefore, background correction has been applied by a linear
fit to the static tissue. However, eddy current related phase
contributions may vary between scanners and potentially
fitting models including higher order terms may be needed
for comparisons between different vendors, particularly for
the more distant slices. Furthermore, a simple approach to
verify the precision of the applied background compensation
is missing for clinical routine and the correction may be
insufficient.30
The different acquisition volumes applied in this study
could represent a factor leading to disagreement in flow
parameters due to various isocenter distances regarding
P2–P9. Yet, comparison of both whole heart sequences
showed significant differences in forward flow volume and
peak velocity for many planes and segments, thus demonstrat-
ing that the definition of the acquisition volume may not be
the only influential factor.
4D Flow MR sequences in this study were scanner-
specific containing variations in acquisition parameters which
may have contributed to the observed significant differences.
Multiple research groups studied the impact of acquisition
parameters on results of different flow parameters and WSS.
Low spatial resolution had the most influence on WSS lead-
ing to underestimation of WSS values.31–33 Stalder et al
showed with a synthetic model that, eg, for a voxel length of
1 mm WSS is lowered to 60% of its actual value and
decreases to above 30% for a voxel length of 10 mm, whereas
total blood flow remained comparatively steady.31 In this
study, the highest acquired voxel size and thereby lowest spa-
tial resolution was obtained at scanner I, but WSS values were
lowest at scanner III. Also lower values for forward flow vol-
ume and peak velocity were found at scanner III, which
should not be affected by the difference in spatial resolution,
but which could be related to the different acceleration tech-
niques applied at the scanners (Autocalibrating Reconstruc-
tion for Cartesian sampling, GeneRalized Autocalibrating
Partially Parallel Acquisition, Sensitivity Encoding). Highest
VENC was set at scanner I and may have induced higher
WSS values as Zimmermann et al detected.33 However, in
scans acquired at scanner II, also higher WSS values were
measured without significant difference to the values mea-
sured at scanner I, although the VENC was lower. Further-
more, varieties in temporal resolution and the amount of
reconstructed cardiac phases could have led to determination
of slightly different absolute time points of the peak systolic
phase between the scans, elevating the variability in WSS
results.
Montalba et al showed greater underestimation and var-
iability for flow parameters when using 4D flow acquisitions
with lower temporal resolutions.34 In this study, the lowest
temporal resolution was obtained at scanner II, but
lowest flow parameters resulted from 4D flow images
acquired at scanner III. The lowest forward flow volume
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could be partly attributed to the difference in ECG gating, as
the only prospectively gated sequence, which does not cover
the entire cardiac cycle missing the late diastolic phases, was
used at scanner III. Although aortic flow is primarily expected
in the systolic phases in healthy volunteers, prospective gating
could cause lower forward flow volumes missing the early sys-
tolic flow due to a delay in detecting the R-wave.
Considering knowledge on the influence of acquisition
parameters on the results the differences in protocol settings
represent potential confounders and sequence parameters
should be matched as far as possible between different scan-
ners. However, as each scanner type presents individual speci-
fications, individual adjustments are needed. Furthermore,
individual and site-dependent adjustments in protocol set-
tings can be necessary for optimizing the vendor-provided
protocols from a clinical perspective. Additional site-
associated influence factors such as potential operator-
dependent variabilities in levels of experience with 4D Flow
MR planning at the different sites could have caused the dif-
ferences as well.
Regarding scan-rescan reliability, the results showed no
significant differences for all parameters and highlighted for-
ward flow volume as most constant parameter with excellent
scan-rescan and intra- and interobserver agreement. Markl
et al also found excellent scan-rescan, intra- and interobserver
agreement for calculation of total flow and peak velocity
vs. greater variability for WSS.35 Compared to flow parame-
ters, evaluation of WSS seems to depend more on the defini-
tion of vessel wall contours, leading to more variability by
differing segmentation contouring.31,33,35 This might explain
the wider CI for WSS parameters reached by the inter-
observer agreement. The broader CI becomes particularly
clear outreaching the level of the scan-rescan CI for
maximum WSS.
In relation to inter- and intraobserver reproducibility,
scan-rescan comparison resulted in higher variability. This
may likely be determined by differences in repositioning of
the coil and image planning with, eg, various isocenter loca-
tions between both acquisitions. Further, length of still
recumbency was longer before the first 4D Flow MR acquisi-
tion than the rescan and may have induced hemodynamic
changes, although blood pressure and heart frequency were
similar between both scans. In addition, the scan-rescan dif-
ference was statistically non-significant, and ICC reached
good-excellent agreement.
Limitations
The study consisted of only a smaller number of healthy vol-
unteers with a high drop-out rate and did not include
patients or elderly, but it was already challenging to organize
and implement this quantity of scans at different sites
throughout Germany. Reflecting the status quo, each site
used their individual and vendor-provided standard 4D Flow
MR sequence, instead of agreeing on a common adapted
sequence. Thus, acquisition parameters differed between the
scans influencing the inter-vendor agreement but reflected
the real-life setting and current level of standardization. Addi-
tional scans with matched sequence parameters could not be
performed for logistical reasons and the study refrained of a
comparison of 4D Flow MR results with a reference gold
standard, eg, 2D flow acquisitions or invasive hemodynamic
measurements. Therefore, the results do not allow conclu-
sions about which of the 4D flow sequences is the most pre-
cise or if the differences were more vendor or site associated,
but neither of those was actually this study’s aim. Also,
changes in hemodynamic parameters during the various time
between 4D Flow MR examinations at the different sites may
have elevated the inter-vendor variability, however as all
blood pressure measurements lay within a narrow range and
the volunteers were all healthy, the impact should be small.
No adjustment was applied for the significance level
due to the explorative character of the study. However, hier-
archical testing was used by applying first the global test on
differences between scanners before interpreting pairwise
comparisons of two scanners.
Conclusion
4D flow derived aortic hemodynamic parameters assessed
with various vendor-provided and clinical 4D Flow MR pro-
tocols at the three different sites are not equivalent. Overall,
the plane positioned at the sinotubular junction showed most
inter-vendor stability and agreement. To enable large multi-
center studies and patient follow-up examinations at various
scanners and sites further investigation of the differences of
sequences across centers and vendors is needed. The identifi-
cation of confounders will help to overcome current limita-
tions. Due to the lack of existing commercial 4D Flow MR
sequences for clinical routine across platforms and centers,
longitudinal studies and patient’s follow-up examinations
should take place at the same scanner.
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